Altera (ALTR) was upgraded at J.P. Morgan to overweight from neutral. Company is leveraged to higher carrier spending in China, J.P. Morgan said.
Boston Scientific (BDX) was upgraded at Piper Jaffray to overweight. Twelve-month price target is $18. Company is in the second leg of a multiyear move, Piper Jaffray said.
Bloomin Brands (BLMN) was upgraded at J.P. Morgan to overweight. Share weakness overshadows expanding margins, J.P. Morgan said.
Covance (CVD) was downgraded at Goldman Sachs to neutral from buy. Valuation call, based on a 12-month price target of $101.
Must Read: Analysts' Actions: BBY FUEL FWLT NUS TWTR
Gap (GPS) was upgraded at Sterne Agee to buy from underperform. Twelve-month price target is $44. Stock has lagged, and a solid holiday season sets the company up well for 2014, Sterne Agee said.Hilton Worldwide (HLT - Get Report) was initiated with a neutral rating at Robert Baird. Valuation call, based on a twelve-month price target of $22, Robert Baird said.
Hilton Worldwide was initiated at UBS with a neutral rating. Valuation call with strong fundamentals, UBS said. Twelve-month price target is $23.
Marriott (MAR) was upgraded at Morgan Stanley to overweight. Twelve-month price target is $62. Domestic lodging outlook is accelerating, Morgan Stanley said.
Motorola Solutions (MSI) was upgraded at Citigroup to buy. Twelve-month price target is $75. Company is leveraged to an enterprise recovery and will likely buy back more shares, Citigroup said.